Innovation Pharmaceuticals Inc (IPIX): Otezla's sales growth is badly yo-yo...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: groton68 post# 242155

Friday, 09/21/2018 11:50:44 AM

Friday, September 21, 2018 11:50:44 AM

Otezla's sales growth is badly yo-yoing, plus it did not do that convincingly in ulcerative colitis trial. So I say, maybe ...

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

Only $200 per official company press release!